Clinical Trial Leads to Remission for Leukemia Patient
FDA endorses cancer therapy done in Nebraska Medicine trials
Modal window
You're leaving our website
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?